ICU Medical Valuation
| ICUI Stock | USD 154.35 0.77 0.50% |
At this time, the entity appears to be fairly valued. ICU Medical retains a regular Real Value of $155.71 per share. The prevalent price of the entity is $154.35. Our model calculates the value of ICU Medical from analyzing the entity fundamentals such as operating margin of 0.05 %, and Return On Asset of 0.0166 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ICU Medical's valuation include:
Price Book 1.4107 | Enterprise Value | Enterprise Value Ebitda 12.6299 | Price Sales 1.6869 | Forward PE 14.3885 |
Fairly Valued
Today
Please note that ICU Medical's price fluctuation is very steady at this time. Calculation of the real value of ICU Medical is based on 3 months time horizon. Increasing ICU Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ICU Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ICU Stock. However, ICU Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 154.35 | Real 155.71 | Target 182.67 | Hype 154.46 | Naive 159.43 |
The intrinsic value of ICU Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence ICU Medical's stock price.
Estimating the potential upside or downside of ICU Medical helps investors to forecast how ICU stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ICU Medical more accurately as focusing exclusively on ICU Medical's fundamentals will not take into account other important factors: When choosing an evaluation method for ICU Medical, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
ICU Medical Cash |
|
ICU Revenue by Product
ICU Medical Total Value Analysis
ICU Medical is currently anticipated to have valuation of 4.07 B with market capitalization of 3.76 B, debt of 1.39 B, and cash on hands of 285.59 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ICU Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.07 B | 3.76 B | 1.39 B | 285.59 M |
ICU Medical Investor Information
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. ICU Medical has Price/Earnings To Growth (PEG) ratio of 1.7. The entity recorded a loss per share of 0.32. The firm had not issued any dividends in recent years. ICU Medical had 3:2 split on the 18th of March 2002. ICU Medical may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.ICU Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ICU Medical has an asset utilization ratio of 55.06 percent. This signifies that the Company is making $0.55 for each dollar of assets. An increasing asset utilization means that ICU Medical is more efficient with each dollar of assets it utilizes for everyday operations.ICU Medical Profitability Analysis
Taking into consideration ICU Medical's profitability measurements, ICU Medical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess ICU Medical's ability to earn profits and add value for shareholders.Net Income | First Reported 1991-03-31 | Previous Quarter -3.4 M | Current Value -15.7 M | Quarterly Volatility 13.2 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.55 | 0.3676 |
|
|
For ICU Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ICU Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ICU Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ICU Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ICU Medical over time as well as its relative position and ranking within its peers.
ICU Medical Earnings per Share Projection vs Actual
The next projected EPS of ICU Medical is estimated to be 1.76 with future projections ranging from a low of 1.66 to a high of 1.91. ICU Medical's most recent 12-month trailing earnings per share (EPS TTM) is at -0.32. Please be aware that the consensus of earnings estimates for ICU Medical is based on EPS before non-recurring items and includes expenses related to employee stock options.ICU Medical Earnings Estimation Breakdown
The calculation of ICU Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ICU Medical is estimated to be 1.76 with the future projection ranging from a low of 1.66 to a high of 1.91. Please be aware that this consensus of annual earnings estimates for ICU Medical is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
1.66 Lowest | Expected EPS | 1.91 Highest |
ICU Medical Earnings Projection Consensus
Suppose the current estimates of ICU Medical's value are higher than the current market price of the ICU Medical stock. In this case, investors may conclude that ICU Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ICU Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 7 | 81.25% | 1.91 | 1.76 | -0.32 |
ICU Medical Ownership Allocation
The majority of ICU Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in ICU Medical to benefit from reduced commissions. Therefore, third-party entities are subject to a different set of regulations than regular investors in ICU Medical. Please pay attention to any change in the institutional holdings of ICU Medical as this could imply that something significant has changed or is about to change at the company.ICU Medical Profitability Analysis
The company reported the previous year's revenue of 2.23 B. Net Income was 732 K with profit before overhead, payroll, taxes, and interest of 822.04 M.About ICU Medical Valuation
An absolute valuation paradigm, as applied to ICU Stock, attempts to find the value of ICU Medical based on its fundamental and basic technical indicators. By analyzing ICU Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ICU Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ICU Medical. We calculate exposure to ICU Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ICU Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 819.7 M | 860.6 M | |
| Operating Profit Margin | 0.05 | 0.05 | |
| Gross Profit Margin | 0.37 | 0.55 |
ICU Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 24.9 M | |
| Quarterly Earnings Growth Y O Y | -0.238 | |
| Forward Price Earnings | 14.3885 |
ICU Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of ICU Medical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ICU we look at many different elements of the entity such as ICU's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ICU Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ICU Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ICU Medical's worth.Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |